ATE211923T1 - Parenterale immunisierung gegen rotavirus - Google Patents

Parenterale immunisierung gegen rotavirus

Info

Publication number: ATE211923T1
Authority: AT; Austria
Prior art keywords: rotavirus; immunization against; parenteral immunization; against rotavirus; vaccine
Prior art date: 1992-07-10

Application number

AT93917119T

Other languages

English (en)

Inventor

Mary K Estes

Margaret E Conner

Original Assignee

Baylor College Medicine

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-07-10

Filing date

1993-07-12

Publication date

2002-02-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25430523&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE211923(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1993-07-12 Application filed by Baylor College Medicine filed Critical Baylor College Medicine

2002-02-15 Application granted granted Critical

2002-02-15 Publication of ATE211923T1 publication Critical patent/ATE211923T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Microbiology (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Mycology (AREA)
Epidemiology (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Gastroenterology & Hepatology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
General Engineering & Computer Science (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Catalysts (AREA)
Medicinal Preparation (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AT93917119T 1992-07-10 1993-07-12 Parenterale immunisierung gegen rotavirus ATE211923T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US07/911,593 US6780630B1 (en)	1992-07-10	1992-07-10	Parenteral immunization against rotavirus
PCT/US1993/006543 WO1994001134A1 (en)	1992-07-10	1993-07-12	Parenteral immunization against rotavirus

Publications (1)

Publication Number	Publication Date
ATE211923T1 true ATE211923T1 (de)	2002-02-15

Family

ID=25430523

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93917119T ATE211923T1 (de)	1992-07-10	1993-07-12	Parenterale immunisierung gegen rotavirus

Country Status (14)

Country	Link
US (1)	US6780630B1 (de)
EP (1)	EP0603386B1 (de)
JP (1)	JPH07501558A (de)
KR (2)	KR100354587B1 (de)
AT (1)	ATE211923T1 (de)
AU (1)	AU673370B2 (de)
CA (1)	CA2116971A1 (de)
DE (1)	DE69331459T2 (de)
DK (1)	DK0603386T3 (de)
ES (1)	ES2166763T3 (de)
IL (1)	IL106306A (de)
NO (1)	NO307815B1 (de)
PT (1)	PT603386E (de)
WO (1)	WO1994001134A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5626851A (en) *	1987-11-30	1997-05-06	The Wistar Institute Of Anatomy And Biology	Rotavirus reassortant vaccine
US6210677B1 (en) *	1993-01-29	2001-04-03	Robert C. Bohannon	Method to reduce the physiologic effects of drugs on mammals
CA2224697A1 (en)	1995-06-14	1997-01-03	Peng Tian	Rotavirus enterotoxin nsp4 and methods of using same
US6673355B1 (en)	1995-06-14	2004-01-06	Baylor College Of Medicine	Rotavirus enterotoxin NSP4 and methods of using same
AU2008296241B2 (en)	2007-09-04	2014-07-24	The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention	Thermal inactivation of rotavirus
CA2763359C (en)	2009-05-12	2021-07-27	Baoming Jiang	New human rotavirus strains and vaccines
KR20170028992A (ko) *	2014-07-18	2017-03-14	엠에스디 웰컴 트러스트 힐레맨 랩스 피브이티. 리미티드	열안정성 동결 건조된 로타바이러스 백신 제형 및 이의 제조 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2483779A1 (fr) *	1980-06-05	1981-12-11	Synthelabo	Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins
US4341763A (en) *	1981-03-10	1982-07-27	Smithkline-Rit	Methods of vaccinating humans against rotavirus infection
US4636385A (en) *	1985-02-15	1987-01-13	The Wistar Institute Of Anatomy & Biology	Vaccine, method for its preparation, and use thereof in vaccinating humans against rotavirus infection
US4861864A (en) *	1985-05-14	1989-08-29	Albert Einstein College of Medicine of Yeshiva University (a Div. of Yeshiva University)	Rotavirus antigens
US4704275A (en) *	1985-08-26	1987-11-03	The United States Of America As Represented By The Department Of Health And Human Services	Vaccine against rotavirus diseases
EP0251467A3 (de) *	1986-06-20	1988-07-20	Abbott Laboratories	Zusammensetzungen und Verfahren zum Gebrauch eines Haupt-Aussen-Kapsid-Proteins (VP7) des Rotavirus SA-11
US4927628A (en) *	1987-09-21	1990-05-22	The United States Of America As Represented By The Department Of Health And Human Services	Vaccine against rotavirus diseases and method of preparing same
US5147639A (en) *	1990-06-19	1992-09-15	Ambico, Inc.	Type-c rotavirus cultures and uses therefor
KR0171434B1 (ko) *	1990-11-16	1999-02-01	윌리엄 케이. 슈버트	인체 로타바이러스, 백신 및 방법

1992
- 1992-07-10 US US07/911,593 patent/US6780630B1/en not_active Expired - Fee Related
1993
- 1993-07-12 ES ES93917119T patent/ES2166763T3/es not_active Expired - Lifetime
- 1993-07-12 JP JP6503564A patent/JPH07501558A/ja not_active Ceased
- 1993-07-12 DK DK93917119T patent/DK0603386T3/da active
- 1993-07-12 WO PCT/US1993/006543 patent/WO1994001134A1/en not_active Ceased
- 1993-07-12 CA CA002116971A patent/CA2116971A1/en not_active Abandoned
- 1993-07-12 KR KR1020017006840A patent/KR100354587B1/ko not_active Expired - Fee Related
- 1993-07-12 AU AU46740/93A patent/AU673370B2/en not_active Ceased
- 1993-07-12 AT AT93917119T patent/ATE211923T1/de not_active IP Right Cessation
- 1993-07-12 KR KR1019940700778A patent/KR940702388A/ko not_active Ceased
- 1993-07-12 EP EP93917119A patent/EP0603386B1/de not_active Revoked
- 1993-07-12 DE DE69331459T patent/DE69331459T2/de not_active Expired - Fee Related
- 1993-07-12 PT PT93917119T patent/PT603386E/pt unknown
- 1993-07-12 IL IL10630693A patent/IL106306A/en not_active IP Right Cessation
1994
- 1994-03-09 NO NO940827A patent/NO307815B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0603386B1 (de)	2002-01-16
DE69331459D1 (de)	2002-02-21
IL106306A (en)	2002-07-25
PT603386E (pt)	2002-06-28
DE69331459T2 (de)	2002-06-20
KR100354587B1 (ko)	2002-10-04
DK0603386T3 (da)	2002-03-11
KR940702388A (ko)	1994-08-20
AU673370B2 (en)	1996-11-07
CA2116971A1 (en)	1994-01-20
EP0603386A1 (de)	1994-06-29
EP0603386A4 (en)	1996-05-29
US6780630B1 (en)	2004-08-24
AU4674093A (en)	1994-01-31
NO307815B1 (no)	2000-06-05
WO1994001134A1 (en)	1994-01-20
NO940827D0 (no)	1994-03-09
NO940827L (no)	1994-05-09
JPH07501558A (ja)	1995-02-16
IL106306A0 (en)	1993-11-15
ES2166763T3 (es)	2002-05-01

Legal Events

Date	Code	Title
2002-06-15	UEP	Publication of translation of european patent specification
2004-04-15	REN	Ceased due to non-payment of the annual fee
2006-10-15	RZN	Patent revoked

Publication	Publication Date	Title
ATE242319T1 (de)	2003-06-15	Deletionsmutanten als impfstoffe gegen cholera
DE69637481D1 (de)	2008-05-15	Aus immunisierten Xenomäusen stammende menschliche Antikörper gegen IL-8
ATE295895T1 (de)	2005-06-15	Genetischer impfstoff gegen den immunschwäche virus
ID21338A (id)	1999-05-27	Metoda untuk menghasilkan kekebalan aktif dengan vaksin gabungan
DE60331412D1 (de)	2010-04-08	Hiv-vakzine und anwendungsverfahren
DE69331459D1 (de)	2002-02-21	Parenterale immunisierung gegen rotavirus
DK0536302T3 (da)	1997-09-29	Forbedrede adjuvanser og vacciner
DE69738641D1 (de)	2008-05-29	Lebend-impfstoff gegen heliobacter pylori
TW340873B (en)	1998-09-21	Chicken anaemia agent vaccine
NL300112I1 (nl)	2003-04-01	Vaccin tegen dermatomycosis.
DK0563254T3 (da)	1996-02-12	Anvendelse af IL-4 til forstærkning af immunrespons på immunogener i vacciner
PT636030E (pt)	2004-05-31	Vacina de bacterina-toxoide de pasteurella haemolytica tipo a-1
PT1194450E (pt)	2005-03-31	Vacina inactivada contra a calicivirose felina
ES2055610T3 (es)	1994-08-16	Vacuna contra hrsv.
ES2102836T3 (es)	1997-08-01	El empleo de vacunas antihelminticas en el control de la enfermedad parasitaria asociada con la perdida de la inmunidad natural.
ATE145335T1 (de)	1996-12-15	Kreuzreaktive immunisierung gegen influenza
NO980721L (no)	1998-04-22	Vaksiner
RU99110617A (ru)	2001-02-20	Способ сезонной вакцинопрофилактики полиомиелита на крайнем севере
FR2698271B1 (fr)	1994-12-30	Vaccin contre le virus de la leucémie bovine, nouveau peptide immunogène et kit de vaccination.
RU2004102296A (ru)	2005-07-10	Способ вакцинопрфилактики взрослых против дифтерии и столбняка на крайнем севере
RU2002130182A (ru)	2004-05-20	Способ вакцинопрофилактики полиомиелита на крайнем севере
RU96123912A (ru)	1999-02-27	Способ иммунопрофилактики экспериментальной лепрозной инфекции
RU2000112250A (ru)	2002-05-20	Способ сезонной вакцинопрофилактики паротита на крайнем севере
MX9707402A (es)	1998-06-30	Vacunas inactivadas mejoradas.
RU2004130267A (ru)	2006-03-27	Способ вакцинации детей против краснухи на крайнем севере